| 产品编号 | 图片 | CAS No. | 名称及描述 | 规格 | 价格 | 分子式 | 快速订购 |
|---|---|---|---|---|---|---|---|
| GC30922-25mg |
|
330461-64-8 |
SIRT2 Inhibitor II (AK-1) - Glpbio |
0 | 需询价 | C19H21N3O5S | |
| GC30922-10mg |
|
330461-64-8 |
SIRT2 Inhibitor II (AK-1) - Glpbio |
0 | 需询价 | C19H21N3O5S | |
| GC30922-5mg |
|
330461-64-8 |
SIRT2 Inhibitor II (AK-1) - Glpbio |
0 | 需询价 | C19H21N3O5S | |
| GC30922-10mM(1mLinDMSO) |
|
330461-64-8 |
SIRT2 Inhibitor II (AK-1) - Glpbio |
0 | 需询价 | C19H21N3O5S | |
| GC30921-100mg |
|
52-51-7 |
Bronopol (BNPD) - Glpbio |
0 | 需询价 | C3H6BrNO4 | |
| GC30921-10mM(1mLinDMSO) |
|
52-51-7 |
Bronopol (BNPD) - Glpbio |
0 | 需询价 | C3H6BrNO4 | |
| GC30920-100mg |
|
677746-25-7 |
K 01-162 (K162) - Glpbio |
0 | 需询价 | C15H14BrN | |
| GC30920-50mg |
|
677746-25-7 |
K 01-162 (K162) - Glpbio |
0 | 需询价 | C15H14BrN | |
| GC30920-10mg |
|
677746-25-7 |
K 01-162 (K162) - Glpbio |
0 | 需询价 | C15H14BrN | |
| GC30920-5mg |
|
677746-25-7 |
K 01-162 (K162) - Glpbio |
0 | 需询价 | C15H14BrN | |
| GC30920-1mg |
|
677746-25-7 |
K 01-162 (K162) - Glpbio |
0 | 需询价 | C15H14BrN | |
| GC30920-10mM(1mLinDMSO) |
|
677746-25-7 |
K 01-162 (K162) - Glpbio |
0 | 需询价 | C15H14BrN | |
| GC30919-100mg |
|
304-84-7 |
Etamivan (Ethamivan) - Glpbio |
0 | 需询价 | C12H17NO3 | |
| GC30919-10mM(1mLinDMSO) |
|
304-84-7 |
Etamivan (Ethamivan) - Glpbio |
0 | 需询价 | C12H17NO3 | |
| GC30918-100mg |
|
443103-97-7 |
A2A receptor antagonist 1 - Glpbio |
0 | 需询价 | C16H12FN5O | |
| GC30918-50mg |
|
443103-97-7 |
A2A receptor antagonist 1 - Glpbio |
0 | 需询价 | C16H12FN5O | |
| GC30918-10mg |
|
443103-97-7 |
A2A receptor antagonist 1 - Glpbio |
0 | 需询价 | C16H12FN5O | |
| GC30918-5mg |
|
443103-97-7 |
A2A receptor antagonist 1 - Glpbio |
0 | 需询价 | C16H12FN5O | |
| GC30918-1mg |
|
443103-97-7 |
A2A receptor antagonist 1 - Glpbio |
0 | 需询价 | C16H12FN5O | |
| GC30918-10mM(1mLinDMSO) |
|
443103-97-7 |
A2A receptor antagonist 1 - Glpbio |
0 | 需询价 | C16H12FN5O | |
小泰
|
010-60710855
|